Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : THE SLIGHTLY MODERATED BOXING RING -- Ignore unavailable to you. Want to Upgrade?

To: Lane3 who wrote (10771)	4/25/2002 5:00:53 PM
From: Solon	Respond to of 21057

Yikes! No more baked potatoes?! This is hard to hear...

To: Lane3 who wrote (10771)	4/25/2002 5:09:12 PM
From: one_less	Read Replies (1) \| Respond to of 21057

Link between research and application: Got cloned milk? Infigen, a DeForest, Wis., biotechnology company, does. With 34 of its 170 cloned cattle in a "milking barn," Infigen is ready to place bottles of the herd's output on America's breakfast tables...Seattle Times 3/27/02 WORCESTER, Mass., April 16 /PRNewswire/ -- Advanced Cell Technology, Inc. (ACT) announced today the license of animal cloning technology to PPL Therapeutics (PPL). The worldwide nonexclusive license will cover PPL's use of somatic cell nuclear transfer (cloning) technology in the development of genetically modified pigs for potential use in xenotransplantation (the use of animal-derived tissues for human transplantation). Researchers from Wake Forest University School of Medicine and Advanced Cell Technology (ACT) of Worcester, Mass. report in today's Science that they have developed a large variety of specialized cell types -- including heart and brain cells -- from embryonic monkey stem cells through a process called parthenogenesis. In November 1998, Advanced Cell Technologies (ACT) of Worcester, MA, announced that it fused a human nucleus with the cytoplasm from a cow's ovum.